Getinge AB
STO:GETI B
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
165.35
239.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Getinge AB
Getinge AB
Cash & Cash Equivalents
Getinge AB
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Getinge AB
STO:GETI B
|
Cash & Cash Equivalents
kr2.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Cash & Cash Equivalents
kr2.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Cash & Cash Equivalents
kr666.3m
|
CAGR 3-Years
29%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Cash & Cash Equivalents
kr137.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
9%
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Cash & Cash Equivalents
kr923m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Cash & Cash Equivalents
kr226.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Getinge AB
Glance View
Getinge AB, rooted in the lush landscapes of Sweden, has steadily evolved into a global leader in the medical technology sector. The company began its journey by manufacturing traditional sterilizers over a century ago. Over time, Getinge has carefully navigated and adapted to the ever-changing dynamics of the healthcare industry, positioning itself squarely at the intersection of innovation and practicality. Today, Getinge specializes in a broad spectrum of medical equipment and systems, focusing on critical care, surgery, and infection prevention. This focus is intricately designed to cater to hospitals and healthcare facilities worldwide, ensuring that patients receive the highest standard of care during complex procedures and critical conditions. Revenue streams for Getinge are as diversified as its product portfolio, comprising equipment sales, service contracts, and consumables. The company’s product offerings range from sophisticated ventilators and state-of-the-art heart-lung machines, to efficient sterilization and surgical workflow products. Beyond simply selling devices, Getinge builds sustainable revenue through long-term service agreements and the sale of replacement parts and consumables, which are essential for the ongoing, optimal operation of its technologically advanced machinery. This strategic emphasis on combining cutting-edge product development with a robust support infrastructure underscores Getinge’s business model, ensuring loyalty and ongoing relationships with healthcare institutions globally.
See Also
What is Getinge AB's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.7B
SEK
Based on the financial report for Dec 31, 2023, Getinge AB's Cash & Cash Equivalents amounts to 2.7B SEK.
What is Getinge AB's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
16%
Over the last year, the Cash & Cash Equivalents growth was -52%. The average annual Cash & Cash Equivalents growth rates for Getinge AB have been -23% over the past three years , 16% over the past five years .
You don't have any saved screeners yet